Yeztugo 463.5 mg/1.5 mL (309 mg/mL) injection Images
Generic Name: lenacapavir
This medication has been identified as Yeztugo 463.5 mg/1.5 mL (309 mg/mL) injection. It is supplied by Gilead Sciences, Inc.
Yeztugo is used in the treatment of Pre-Exposure Prophylaxis of HIV and belongs to the drug class miscellaneous antivirals. Yeztugo 463.5 mg/1.5 mL (309 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Yeztugo
- Generic Name
- lenacapavir
- Strength
- 463.5 mg/1.5 mL (309 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous antivirals
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Gilead Sciences, Inc.
- National Drug Code (NDC)
- 61958-3402
See also:
More about Yeztugo (lenacapavir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous antivirals
- Breastfeeding
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.